Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Blunist, the Cohen report shows over $167 MILLION in Revenues over the next 5

Jan 06, 2009 07:44AM
2
Jan 06, 2009 08:19AM

Blunist, the Cohen report shows over $167 MILLION in Revenues over the next 5

posted on Jan 06, 2009 11:07AM

I agree also but for the reason you have stated and as ihave i have treied ot point out...$267MILLION over the next 6 Years...even if it is on an asscending scale is PEANUTS...

We need that much over the next 2 YEARS for us to see any headway in the PPS...remember as I have said before ,that is only a GROSS REVENUE forecast...take out our operating expenses and taxes and we are near...55% of that and if its a yearly nember you want then even at $267Mm for two years thats only...about 70-75MM a year...NET...or 11.667 EPS...that beats the Cohen report by double(2011FY)...throw in a 10 -12 PE and now we're getting to that PPS of $1.10 to 1.20...but we need 130Mm plus a year to get to that area of valuation.

We'll get some bounce with the 336 re-cert for sure...but it won't see anywhere near 1.00 PPS and won't last if the rev's from licensing are anywhere near what Cohen is projecting...in fact 20MM/yr in licensing rev's after a re-cert to me would be a failure...even double that would be IMO

7
Jan 07, 2009 09:53AM
1
Jan 07, 2009 01:53PM
1
Jan 07, 2009 02:44PM
Share
New Message
Please login to post a reply